Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2005

01-06-2005 | Original Articles

Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage

Authors: Miquel Porta, Xavier Fabregat, Núria Malats, Luisa Guarner, Alfredo Carrato, Ana de Miguel, Laura Ruiz, Manuel Jariod, Sergi Costafreda, Susana Coll, Juan Alguacil, Josep M. Corominas, Ricard Solà, Antonio Salas, Francisco X. Real, the PANKRAS II Study Group

Published in: Clinical and Translational Oncology | Issue 5/2005

Login to get access
Metadata
Title
Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage
Authors
Miquel Porta
Xavier Fabregat
Núria Malats
Luisa Guarner
Alfredo Carrato
Ana de Miguel
Laura Ruiz
Manuel Jariod
Sergi Costafreda
Susana Coll
Juan Alguacil
Josep M. Corominas
Ricard Solà
Antonio Salas
Francisco X. Real
the PANKRAS II Study Group
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 5/2005
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02712816

Other articles of this Issue 5/2005

Clinical and Translational Oncology 5/2005 Go to the issue

Original Articles

Tolerabilidad y efectividad del citrato de fentanilo oral transmucosa en el tratamiento a largo plazo del dolor irruptivo en pacientes oncológicos: estudio ECODIR

Editorial

Postoperative radiotherapy with simultaneous chemotherapy in high-risk squamous cell carcinoma of the head and neck: a novel standard that opens new questions

News

News

Educational Review

Embryonic tumours of the central nervous system

Case Reports

Local recurrence and metastatic disease in a typical N1 carcinoid bronchial tumour

Original Articles

Análisis coste-efectividad de samario-153 (Quadramet®) en el tratamiento del dolor en pacientes con cáncer de próstata y metástasis óseas
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits